Toronto Dominion Bank lifted its stake in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 14.8% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 158,545 shares of the medical instruments supplier’s stock after purchasing an additional 20,441 shares during the period. Toronto Dominion Bank’s holdings in DENTSPLY SIRONA were worth $7,861,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently added to or reduced their stakes in the company. BlackRock Inc. boosted its holdings in DENTSPLY SIRONA by 1.8% in the 4th quarter. BlackRock Inc. now owns 14,334,332 shares of the medical instruments supplier’s stock valued at $533,380,000 after purchasing an additional 257,243 shares during the last quarter. Veritas Asset Management LLP boosted its holdings in DENTSPLY SIRONA by 0.6% in the 1st quarter. Veritas Asset Management LLP now owns 13,549,320 shares of the medical instruments supplier’s stock valued at $671,911,000 after purchasing an additional 76,545 shares during the last quarter. Mackenzie Financial Corp boosted its holdings in DENTSPLY SIRONA by 17.3% in the 4th quarter. Mackenzie Financial Corp now owns 10,090,056 shares of the medical instruments supplier’s stock valued at $375,451,000 after purchasing an additional 1,490,134 shares during the last quarter. Morgan Stanley boosted its holdings in DENTSPLY SIRONA by 1,233.9% in the 3rd quarter. Morgan Stanley now owns 5,242,702 shares of the medical instruments supplier’s stock valued at $197,860,000 after purchasing an additional 4,849,652 shares during the last quarter. Finally, Geode Capital Management LLC boosted its holdings in DENTSPLY SIRONA by 6.6% in the 4th quarter. Geode Capital Management LLC now owns 2,997,698 shares of the medical instruments supplier’s stock valued at $111,355,000 after purchasing an additional 185,780 shares during the last quarter. 95.83% of the stock is owned by institutional investors and hedge funds.

In related news, insider William E. Newell sold 3,000 shares of the company’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $54.73, for a total transaction of $164,190.00. Following the sale, the insider now directly owns 28,212 shares of the company’s stock, valued at approximately $1,544,042.76. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Michael J. Coleman sold 9,160 shares of the company’s stock in a transaction that occurred on Friday, May 10th. The stock was sold at an average price of $54.90, for a total transaction of $502,884.00. Following the sale, the director now directly owns 31,383 shares in the company, valued at $1,722,926.70. The disclosure for this sale can be found here. Insiders sold a total of 123,922 shares of company stock worth $6,790,905 over the last three months. Insiders own 0.62% of the company’s stock.

Several research firms have weighed in on XRAY. BidaskClub upgraded shares of DENTSPLY SIRONA from a “buy” rating to a “strong-buy” rating in a report on Wednesday, May 15th. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $61.00 target price on the stock in a report on Saturday, May 11th. Barrington Research upgraded shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $63.00 target price on the stock in a report on Monday, May 6th. HC Wainwright reiterated a “neutral” rating and issued a $55.00 target price (up from $49.00) on shares of DENTSPLY SIRONA in a report on Monday, May 6th. Finally, ValuEngine upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Saturday, May 4th. Eight equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. DENTSPLY SIRONA has an average rating of “Buy” and a consensus price target of $53.55.

Shares of DENTSPLY SIRONA stock traded up $0.89 on Tuesday, reaching $55.32. The company had a trading volume of 17,279 shares, compared to its average volume of 1,856,284. The company has a market capitalization of $12.74 billion, a price-to-earnings ratio of 27.44, a price-to-earnings-growth ratio of 2.03 and a beta of 1.11. DENTSPLY SIRONA Inc has a 52-week low of $33.93 and a 52-week high of $55.88. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.35 and a current ratio of 2.06.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Friday, May 3rd. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. The business had revenue of $946.20 million for the quarter, compared to the consensus estimate of $925.13 million. DENTSPLY SIRONA had a negative net margin of 26.48% and a positive return on equity of 8.99%. The business’s revenue was down 1.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.45 EPS. Equities analysts expect that DENTSPLY SIRONA Inc will post 2.34 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This article was first reported by Watch List News and is the property of of Watch List News. If you are viewing this article on another site, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The correct version of this article can be viewed at https://www.watchlistnews.com/toronto-dominion-bank-grows-stake-in-dentsply-sirona-inc-xray/3017821.html.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Recommended Story: What are gap-up stocks?

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.